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Death as a consequence of aortic catastrophe is a common
event among the middle-aged and retired population. It is
the 12th most common cause of death in the United
States.1 Although abdominal aortic aneurysms (AAAs) and
ascending aortic aneurysms are the more frequent,
descending thoracic aortic aneurysms (TAAs) and thoraco-
abdominal aortic aneurysms (T-AAAs) are not rare, having
an estimated incidence of 10.4 cases per 100,000 person-
years.2 Aortic aneurysms are generally identiﬁed serendip-
itously (although AAA screening programs are being set up
in some countries). The vast majority of aortic disease is
symptom-free. The prevention of early death in exchange
for life-long morbidity is an unacceptable outcome. “Pri-
mum non nocere” e if we are to usefully treat aneurysms, it
is self-evident that the attendant therapeutic risks have to
be contained.
Once identiﬁed, prophylactic aneurysm repair is not
without hazard and the risks can be shown to be related to
patient selection, operator and institutional experience, the
proportion of cases done endovascularly and the complexity
of the repair. We will argue that these phenomena mandate
that aortic repair, particularly complex endovascular aortic
repair, should be restricted to specialist high volume
centers.THE IMPACT OF CASE VOLUME
The modern move to centralize specialized care and/or
high-risk procedures to high-volume centers is generally
accepted as a positive one. That the risk of postoperative
morbidity and mortality after complex procedures is
signiﬁcantly reduced when performed in high-volume
centers has been widely reported.3e5 In 2000 the Leapfrog
Group, an American coalition of 150 large volume health
care purchasers, deﬁned on the basis of clinical outcomes
high-volume centers for AAA repair as those that performed
50 or more elective AAA repairs per year. In 2003 they
suggested that elective AAA repairs should be referred only
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starker: after elective repair of T-AAA, high volume centers
report mortality and paraplegia rates of 5e6% and 3.8e
6.3% respectively.7 A California state-wide audit reported
a 30-day mortality rate of 22% following open elective T-
AAA repair.8 Moreover, T-AAA repair survivors frequently
experience debilitating postoperative complications and all
too often experience prolonged periods of hospitalization
and rehabilitation, poor functional outcome, and appre-
ciable 1 year mortality.
It is no surprise therefore, that caseload is also
a predictor of postoperative mortality after elective repair
of T-AAAs.8 Patients with T-AAAs treated at high volume
centers (HVC) demonstrate a 42% reduction in mortality.
However, the median length of stay (LOS) for surviving
patients increased minimally at HVC. This observation may
reﬂect survival after postoperative complications rather
than the shorter stay associated with early postoperative
death, which is inferred by the further ﬁnding that more
than 40% of patients who died at low volume centers (LVC)
had LOS of 24 h or less. The difference between HVC and
LVC outcomes suggests differences in the peri-operative
management of these patients. This ﬁnding substantiates
the notion that the early expert management of complica-
tions to satisfactory resolution relates to high case volumes.FENESTRATED ENDOGRAFTS
Although there have been continuous improvements in the
devices, ancillary equipment and technique, unsuitable
anatomy (short, large, angled or poor-quality proximal
aortic sealing zones) continues to preclude standard
infrarenal EVAR for a signiﬁcant subset of patients, thereby
denying them the potential advantages of the endovascular
approach.9,10 Fenestrated endografts have been designed
to extend the proximal sealing zone from the infrarenal to
the suprarenal aorta, in order to extend the advantages of
EVAR to patients with these challenging anatomies.
However, fenestrated endovascular aneurysm repair (f-
EVAR) is a demanding and complex endovascular procedure
at every stage of its use: selection; planning and execution.
Its success depends on appropriate experience of the clin-
ical team. The margins for error are small and the conse-
quences of minor errors are severe.
To date, the available literature evaluating f-EVAR is
exclusively provided by high-volume centers. No literature
comparison between HVC and LVC exists. As is the case with
open T-AAA repair, f-EVAR has been largely relegated to
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outcomes and signiﬁcant activities are the ones that have
reported). Nevertheless, the feasibility and utility of fenes-
trated devices for the treatment of pararenal aneurysms is
well established and there are several large published series
that claim satisfactory intermediate-term outcomes. A
recent literature review indicates that f-EVAR can be per-
formed with a 30-day mortality rate of 2.1% (95% CI, 1.2%e
3.7%),11 which is comparable to the 2.7% rate reported
after conventional EVAR and at least equal to the 2.9% rate
reported after equivalent open surgery in highly selected
patients undergoing surgery in high volume specialist
centers.12,13 That the results of treatment for more chal-
lenging aneurysms using complex and novel technologies
should be superﬁcially better than those for “standard”
EVAR is counter-intuitive. The likely explanation is that all of
the series included in the systematic review were published
by “high volume centers”. We contend therefore, that only
these “centers of excellence” are likely to obtain such
favorable outcomes with fenestrated repair and that they
succeed in doing so speciﬁcally because of their focus,
facilities and accumulated experience. Simply put, it is
essential to be abreast of the continuous development of
this evolving technology and imaging and have a high
volume of varied pararenal AAAs to treat in order to form
a basis for good case selection and planning and have
sufﬁcient familiarity with the technological platform and the
expanded armamentarium required to overcome the
learning curve.PLANNING F-EVAR
The preoperative planning of all EVAR procedures is a foun-
dation stone of successful EVAR in general, it is all the more
critical for f-EVAR. Detailed planning that requiresFigure 1. Coronal MIP reconstruction (a) of a juxtarenal aneurysm. To
were performed with a 3D workstation, including a stretch Curved Plan
the target vessels (b).a substantial level of experience and expertise is necessary
to allow the manufacture of devices where the fenestrations
align with their respective target vessels. This speciﬁcally
demands the skilled use of 3-dimensional workstations
(Fig. 1). All of the following are required in order to design
custom-made endografts speciﬁc to individual anato-
mies:14,15 an assessment of proximal and distal sealing zones
(size, surface, angulation), the gap between the partially and
fully deployed endograft and the visceral artery-bearing
aortic wall, the longitudinal distances between target
vessels, angulations of and radial positions between target
vessels, an estimate of vessel wall calciﬁcation and likely
distortion (or not) while using stiff wires, sheaths and
devices. Inexperienced clinicians may be tempted to dele-
gate the planning phase to graft manufacturer planning
centers. This is a risky strategy because, while technically
accurate planning will be provided, it will be devoid of
clinical judgment and compromise. Such grafts may be
a “true ﬁt”, but prove impossible to implant! Nevertheless,
consultative engagement with (rather than delegation to)
planning centers provides invaluable insights regarding
device design limitations and should be considered manda-
tory for new adopters and later used as an expert resource
for planning the more complex repairs. Used irresponsibly,
planning centers can become a way for inexperienced
physicians to gain access to a technique that they never fully
control if they practice outside high volume centers.THE DEVELOPMENT OF F-EVAR AND IMAGING
MODALITIES
Fenestrated endografts have been in a state of constant
technological development since the ﬁrst device was
implanted in the late 1990s. The design has evolved from
being a modular bifurcated endograft with non-reinforceddesign a four-vessel fenestrated endograft, various reconstructions
ar Reconstruction (CPR) to accurately measure the length between
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bearing component with reinforced fenestrations and
separate bifurcated extension below. Even the choice of
bridging stent has changed: we now use balloon expandable
covered stents rather than balloon expandable uncovered
stents.16 In 2004, the ﬁrst devices with integral side
branches were introduced and this was followed by internal
iliac branches and arch fenestrations in 2005. Low proﬁle
devices became available in 2010. The delivery system has
also been modiﬁed to include a “diameter reducing tie”
system, allowing partial deployment of the device (to
facilitate manipulation and repositioning of the fenestration
bearing component). More recently, preloaded wires/cath-
eters have been positioned across the fenestrations to
eliminate the step of fenestration cannulation, shortening
the procedure by removing one step from the process.
There has also been a continuous improvement in the
infrastructure required to perform f-EVAR. The initial cases
were performed with portable C-arms and sizing was ach-
ieved using simple axial imaging. However, it rapidly
became clear that 3D workstations with centerline of ﬂow
reconstructions are essential for accurate planning. In
addition, case complexity mandates high quality operative
imaging and display as well as a good operating theatre
environment. This has led to the use of hybrid operative
rooms, successively upgraded with ﬂat panel detectors and
fusion imaging software (Fig. 2). All of these evolutions have
made the use of f-EVAR technology quicker and easier, but
they have not replaced the need for considerable planning
and operative experience.
In 2004, Cate et al. recognized the need for dedicated
hybrid rooms for advanced endovascular procedures.17 This
novel concept combines advanced imaging systems with an
open surgical environment. In 2010, an Expert Advisory
Group18 representing the Royal College of Radiologists, the
British Society of Interventional Radiology, the Vascular
Society of Great Britain and Ireland, the Vascular Anaes-
thesia Society of Great Britain and Ireland and theFigure 2. Antero-posterior (a) and lateral (b) ﬂuoroscopic views with f
vessels through their respective fenestrations. The completion angiogrCommittee on the Safety of Devices, in association with the
Medicines and Healthcare products Regulatory Agency
(MHRA) was set up to provide guidance for those centers
that have or are currently establishing an EVAR service. One
of the prescribed essential elements for a dedicated EVAR
facility is high quality imaging equipment to facilitate
accurate endograft positioning and deployment in order to
avoid covering important vessels and compromising blood
ﬂow to essential organs such as the brain, the upper limb,
gut or kidneys.
The intra-operative management of this imaging equip-
ment requires a speciﬁc training for the operators
(surgeons, radiologists and radiographers). Intervention-
alists require a detailed knowledge of the ﬂuoroscopic
options including imaging settings, angulation, radiation
exposure and protection. In 2011, Dijkstra et al.19 evaluated
the use of intra-operative guidance by means of C-arm
cone-beam computed tomography (CBCT) and the use of
postoperative CBCT to assess for successful aneurysm
exclusion in fenestrated endovascular aneurysm repair. The
conclusion of their study was that CBCT is a valuable
addition to complicated aortic interventions such as f-EVAR.
CBCT is a potentially useful tool in the intra-operative use of
“fusion imaging”, which is a signiﬁcant evolution of the
established concept of “road-mapping”. In fusion imaging,
ﬂuoroscopy images are overlaid on CT images. Kobeiter
et al.20 have conﬁrmed the value of these advanced imaging
softwares. They reported a case of thoracic endovascular
aortic repair using fusion imaging without the need for any
operative contrast injection.
We should emphasize that these facilities are essentials,
not luxuries, but they do come at considerable expense!
THE LEARNING CURVE ASSOCIATED WITH THE EFFECTIVE
USE OF FENESTRATED ENDOGRAFTS
For individual practitioners, there is a learning curve for
each of sizing and planning, implantation and intra-opera-
tive imaging, peri-operative patient management. Duringusion are required to access the left renal artery and the visceral
am (c) shows patent target vessels and an excluded aneurysm.
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subtleties of sizing, the use of 3D workstations and come to
understand the inﬂuence of varying vessel tortuosity,
calciﬁcation and caliber on the both device design and their
actual implantation, as well as the technical sequences,
“tricks of the trade” and salvage maneuvers. As important is
the development of a specialist team including surgeons,
radiologists, anesthetists, radiographers and nurses.
The current “center of excellence” exponents and their
teams have been involved in the development of the tech-
niques, been highly focused on them and have acquired
a range of “soft skills” required (so often impossible to name,
document and disseminate) over extended periods and
many cases.This learning is reﬂected in their excellent results
obtained through that developmental experience. While all
of the required stages can be taught by proctoring, the
supervision or observation of a handful of cases, each as
a purely technical exercise, is an insufﬁcient strategy in the
safe dissemination of this procedure and all of the complexity
that surrounds it. Furthermore, considering only the device
implantation, a recent paper by Guillou et al., reports that
prolonged procedure times increase the probability of post-
operative mortality and major morbidity e again suggesting
that this is not a procedure for the uninitiated.21
In short, the effective use of f-EVAR demands much more
than the sum of its component parts! This is not to indicate
that new units should not adopt f-EVAR, but doing so requires
a minimum annual enrollment rate (institutional and for the
individual practitioner) to overcome the learning curve.
CONCLUSIONS
There is compelling evidence that suggests that aneurysm
repair (open and EVAR) should be performed in high
volume centers (35e37). We contend that fenestrated
endograft repairs should only be performed in selected
high-volume centers with appropriately dedicated teams,
experience and technical infrastructure if the currently
results reported for this technique are to persist. In our
view, it is inappropriate for a novel high risk solution for
complex aneurysm repair in fragile patients to be generally
disseminated to occasional institutions and operators.
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